EP 0828496 A1 19980318 - USE OF ALENDRONATE FOR THE PREVENTION OF OSTEOPOROSIS
Title (en)
USE OF ALENDRONATE FOR THE PREVENTION OF OSTEOPOROSIS
Title (de)
VERWENDUNG VON ALENDRONAT ZUR VERBEUGUNG DER OSTEOPOROSE
Title (fr)
UTILISATION D'ALENDRONATE POUR PREVENIR L'OSTEOPOROSE
Publication
Application
Priority
- US 9607912 W 19960529
- US 45819595 A 19950602
Abstract (en)
[origin: WO9638156A1] Alendronate, an aminobisphosphonate, can prevent osteoporosis in early post menopausal women.
IPC 1-7
IPC 8 full level
A61K 31/66 (2006.01); A61K 31/663 (2006.01); A61P 3/02 (2006.01); A61P 19/10 (2006.01); A61P 43/00 (2006.01)
IPC 8 main group level
CPC (source: EP KR)
A61K 31/66 (2013.01 - EP KR); A61P 3/02 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9638156 A1 19961205; AU 5882496 A 19961218; AU 709196 B2 19990826; BG 102060 A 19980731; BG 63103 B1 20010430; BR 9609020 A 19990706; CA 2222318 A1 19961205; CN 1192685 A 19980909; CZ 381197 A3 19980617; EA 000677 B1 20000228; EA 199700449 A1 19980625; EE 03306 B1 20001215; EP 0828496 A1 19980318; HU P9900659 A2 20010428; HU P9900659 A3 20021228; IL 118422 A0 19960912; IS 4617 A 19971119; JP H10506648 A 19980630; KR 19990022436 A 19990325; NO 975527 D0 19971201; NO 975527 L 19971201; NZ 308935 A 20000728; PL 323669 A1 19980414; SK 159597 A3 19980603; TR 199701482 T1 19980321; ZA 964465 B 19961211
DOCDB simple family (application)
US 9607912 W 19960529; AU 5882496 A 19960529; BG 10206097 A 19971120; BR 9609020 A 19960529; CA 2222318 A 19960529; CN 96196075 A 19960529; CZ 381197 A 19960529; EA 199700449 A 19960529; EE 9700308 A 19960529; EP 96920553 A 19960529; HU P9900659 A 19960529; IL 11842296 A 19960527; IS 4617 A 19971119; JP 53661696 A 19960529; KR 19970708917 A 19971202; NO 975527 A 19971201; NZ 30893596 A 19960529; PL 32366996 A 19960529; SK 159597 A 19960529; TR 9701482 T 19960529; ZA 964465 A 19960531